Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Adenocarcinoma Locally Advanced”

334 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 334 results

Large-scale testing (Phase 3)WithdrawnNCT03536182
What this trial is testing

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT00089024
What this trial is testing

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Nebraska 29
Testing effectiveness (Phase 2)Ended earlyNCT01921751
What this trial is testing

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer
Radiation Therapy Oncology Group 20
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Early research (Phase 1)Study completedNCT02045602
What this trial is testing

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsPancreatic Adenocarcinoma
Theriva Biologics SL 42
Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Large-scale testing (Phase 3)UnknownNCT00486460
What this trial is testing

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07153289
What this trial is testing

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Who this might be right for
Carcinoma, Pancreatic DuctalPancreatic Neoplasms
University Hospital Tuebingen 38
Not applicableTemporarily Not AvailableNCT07319910
What this trial is testing

Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
NovoCure GmbH
Early research (Phase 1)Study completedNCT02272738
What this trial is testing

Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases 54
Early research (Phase 1)Study completedNCT02227940
What this trial is testing

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic Adenocarcinoma+2 more
Roswell Park Cancer Institute 38
Testing effectiveness (Phase 2)Study completedNCT01222689
What this trial is testing

Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00203892
What this trial is testing

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Chicago 23
Testing effectiveness (Phase 2)Study completedNCT01369420
What this trial is testing

NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Angiodynamics, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)Study completedNCT00075647
What this trial is testing

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00744640
What this trial is testing

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
University Hospital, Basel, Switzerland 46
Not applicableStudy completedNCT01278368
What this trial is testing

Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Università Vita-Salute San Raffaele 150
Early research (Phase 1)Study completedNCT01485744
What this trial is testing

LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 39
Next Page